If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Venn Life Sciences, Chris Bailey on Dunelm, Dixons Carphone and BT plus Glen Goodman on Crypto
Cathal Friel, CEO of Venn Life Sciences (VENN) discusses how their fundraise is going to be used to transform Venn and acquire Open Ophan to target the fragmented orphan drug services market in Europe.
Open Orphan was incorporated in the Republic of Ireland on 18 July 2017 with a strategy and product offering to develop a market leading services platform for pharmaceutical and biotechnology companies seeking to commercialise their products across Europe with a particular focus on drugs treating rare diseases. It has raised over €3 million from investors to build a platform that facilitates obtaining European Medical Agency approval, and/or relevant local approval, and pan-European reimbursement, for launch and commercialisation of orphan and other rare disease drugs.
Chris Bailey founder of Financial Orbit covers:
Dunelm (DNLM)
Dixons Carphone (DC.)
BT (BT.A)
(Interview starts at 11 minutes 30 seconds)
Glen Goodman, former ITV News Business correspondent and now author of, "The Crypto Trader", provides some insight into the world of crypto currency trading.
(Interview starts at 26 minutes 39 seconds)